Safety and Preliminary Efficacy of Recombinant Activated FVII Analog (NN1731) In the Treatment of Joint Bleeds In Congenital Hemophilia Patients with Inhibitors
Bildiriler > Özet Bildiri · 2010
Yazarlar: Erich de Paula, Ramazan Kaan KAVAKLI, Johnny Mahlangu, Yasmin AYOB, Steven R. Lentz, Massimo MORFINI, Laszlo NEMES, Silva Zupancic SALEK, Midori SHIMA, Jerzy WINDYGA, Silke EHRENFORTH, Henning Friis ANDERSEN, Ampaiwan CHUANSUMRIT
52nd Annual Meeting of the American-Society-of-Hematology (ASH), Amerika Birleşik Devletleri, Uluslararası, Sözlü Sunum, Özet Bildiri, 2010-2010, Wos, cilt 116, ss 317-317